SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31

Sonoma Pharmaceuticals, Inc.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$1.12+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $4.31M
P/E (TTM): –
Dividend yield: –

Sonoma Pharmaceuticals, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31	FY 2016 2016-03-31	FY 2015 2015-03-31	FY 2014 2014-03-31	FY 2013 2013-03-31	FY 2012 2012-03-31	FY 2011 2011-03-31	FY 2010 2010-03-31
Cash & Equivalents	2.40	5.37	3.13	3.82	7.40	4.22	3.69	3.69	10	17	7.47	6.14	5.48	7.90	3.35	4.37	6.26
Cash & Short-Term Investments	2.40	5.37	3.13	3.82	7.40	4.22	3.69	3.69	10	17	7.47	6.14	5.48	7.90	3.35	4.37	6.26
Receivables	2.53	2.23	2.90	2.57	2.41	2.81	3.97	3.48	1.54	2.11	1.51	1.52	1.79	1.71	2.15	2.09	–
Inventory	3.65	2.92	2.72	2.86	2.66	2.53	2.18	3.41	2.87	2.22	1.60	1.40	1.09	0.99	0.95	0.73	–
Prepaid Expenses & Other	3.52	1.92	3.54	4.31	3.75	3.22	2.26	1.69	1.55	0.62	1.51	0.59	0.65	0.94	0.51	0.61	–
Other Current Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	0.15	0.07	–	–
Total Current Assets	12	13	13	14	16	13	12	12	16	23	13	9.65	9.54	12	6.96	7.81	–
Property, Plant & Equipment	0.31	0.23	0.37	0.49	0.32	0.36	0.37	0.73	1.14	1.24	0.85	0.80	0.97	0.80	0.81	0.80	–
Gross Property, Plant & Equipment	2.79	2.30	2.75	2.50	2.03	1.83	3.97	4.64	4.71	4.27	3.76	3.55	3.73	3.45	3.32	–	–
Accumulated Depreciation	-2.48	-2.08	-2.38	-2.01	-1.71	-1.47	-3.60	-3.91	-3.57	-3.03	-2.91	-2.75	-2.76	-2.65	-2.52	–	–
Machinery & Equipment	1.80	1.47	1.78	1.62	1.28	1.17	3.01	3.58	3.65	3.32	3.08	2.94	3.07	2.73	–	–	–
Long-Term Investments	–	–	–	–	–	–	–	–	–	–	0	4.54	10	0	–	–	–
Operating Lease Right-of-Use Assets	0.60	0.08	0.29	0.42	0.56	0.77	0.36	0	–	–	–	–	–	–	–	–	–
Deferred Tax Assets	0.88	0.59	1.15	0.95	0.83	0	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	0.06	0.07	0.07	0.07	0.08	0.11	0.06	0.12	0.49	0.08	0.07	0.07	0.13	0.19	0.07	0.05	–
Total Assets	14	14	15	16	19	15	15	14	19	25	14	15	21	13	7.84	8.66	–
Accounts Payable	1.92	0.95	0.61	0.84	1.64	1.77	2.07	1.26	1.27	1.26	1.34	0.93	0.74	0.81	0.82	0.67	–
Short-Term Debt	0.22	0.22	0.32	0.43	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Portion of Long-Term Debt	–	–	–	–	–	0.60	0.48	0.32	0.23	0.12	0.11	0.09	0.14	1.26	1.42	0.91	–
Current Debt	0.22	0.22	0.32	0.43	–	0.60	0.48	0.32	0.23	0.12	0.11	0.09	0.14	1.26	1.42	0.91	–
Current Portion of Leases	0.15	0.06	0.20	0.26	0.25	0.24	0.13	0	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	–	–	–	–	–	0.01	0	–	–	–	–	–	–
Deferred Revenue (Current)	0.28	0.64	0.48	0.16	1.22	0.27	0.23	0.05	0.15	0.35	0.27	0.77	2.63	2.32	1.62	1.81	–
Other Current Liabilities	–	–	–	–	–	–	0	0.27	0	–	–	–	–	–	–	–	–
Total Current Liabilities	4.83	4.10	3.72	3.72	5.82	4.08	4.73	3.59	3.26	3.29	3.55	2.58	7.57	5.13	4.75	4.42	–
Long-Term Debt	–	–	–	–	0	1.31	0	0.01	0.03	0.05	0	0	0.00	0.68	1.82	1.64	–
Long-Term Leases	0.47	0.03	0.09	0.16	0.31	0.53	0.24	0	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	0.62	0.09	0.29	0.42	0.56	0.77	1.00	1.50	–	–	–	–	–	–	–	–	–
Total Liabilities	11	9.28	8.60	8.25	10	9.62	8.94	3.96	3.88	4.03	3.66	2.99	8.73	8.48	8.71	6.96	–
Total Debt	0.22	0.22	0.32	0.43	0	1.91	0.48	0.33	0.26	0.17	0.11	0.09	0.15	1.94	3.24	2.55	–
Preferred Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–
Common Stock	0	0	0	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0	0.00	–
Additional Paid-In Capital	207	207	203	201	197	189	187	184	177	169	166	158	149	145	134	130	–
Retained Earnings	-201	-198	-194	-190	-184	-179	-175	-169	-157	-143	-152	-142	-134	-138	-132	-125	–
Comprehensive Income & Other	-3.24	-4.38	-2.72	-3.42	-4.31	-4.58	-5.61	-4.35	-3.98	-4.18	-3.85	-3.51	-3.07	-2.99	-3.05	-2.90	–
Shareholders' Equity	3.10	4.41	6.14	7.98	8.70	5.36	5.62	7.77	15	21	10	12	12	4.08	-0.87	1.70	7.05
Total Equity	3.10	4.41	6.14	7.98	8.70	5.36	5.62	7.77	15	21	10	12	12	4.08	-0.87	1.70	7.05
Total Liabilities & Equity	14	14	15	16	19	15	15	14	19	25	14	15	21	13	7.84	8.66	–
Shares Outstanding(shares)	1.80	1.63	0.78	0.25	0.16	0.10	0.09	0.07	0.03	0.02	0.02	0.02	0.01	0.01	0.00	0.00	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 38.9%
Operating margin: -6.4%
Net margin: -10.3%
Return on equity, FY2026: -84.6%

Financial strength

Current ratio: 2.99
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 98.0%

Valuation

P/E ratio: –
Price to sales: 0.20
Price to book: 0.65
Dividend yield: –